165 related articles for article (PubMed ID: 27813709)
1. Serum 1,25-Dihydroxyvitamin D as a Biomarker of the Absence of Hypercalciuria in Postsurgical Hypoparathyroidism.
García-Pascual L; Barahona MJ; Perea V; Simó R
J Clin Endocrinol Metab; 2017 Jan; 102(1):259-266. PubMed ID: 27813709
[TBL] [Abstract][Full Text] [Related]
2. Alfacalcidol vs Calcitriol in the Management of Patient With Hypoparathyroidism: A Randomized Controlled Trial.
Saha S; Sreenivas V; Goswami R
J Clin Endocrinol Metab; 2021 Jun; 106(7):2092-2102. PubMed ID: 33616655
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
[TBL] [Abstract][Full Text] [Related]
4. PTH(1-34) for Surgical Hypoparathyroidism: A 2-Year Prospective, Open-Label Investigation of Efficacy and Quality of Life.
Palermo A; Santonati A; Tabacco G; Bosco D; Spada A; Pedone C; Raggiunti B; Doris T; Maggi D; Grimaldi F; Manfrini S; Vescini F
J Clin Endocrinol Metab; 2018 Jan; 103(1):271-280. PubMed ID: 29099939
[TBL] [Abstract][Full Text] [Related]
5. A New Therapeutic Approach Using a Calcilytic (AXT914) for Postsurgical Hypoparathyroidism in Female Rats.
Lim YS; You BH; Kim HB; Lim SH; Song JG; Bae MG; Han HK; Choi YH; Choi HS
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32852547
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide.
Puig-Domingo M; Díaz G; Nicolau J; Fernández C; Rueda S; Halperin I
Eur J Endocrinol; 2008 Nov; 159(5):653-7. PubMed ID: 18703565
[TBL] [Abstract][Full Text] [Related]
7. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.
Rubin MR; Cusano NE; Fan WW; Delgado Y; Zhang C; Costa AG; Cremers S; Dworakowski E; Bilezikian JP
J Clin Endocrinol Metab; 2016 Jul; 101(7):2742-50. PubMed ID: 27144931
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid Hormone Replacement Therapy in Hypoparathyroidism: A Meta-Analysis.
Liu XX; Zhu XY; Mei GH
Horm Metab Res; 2016 Jun; 48(6):377-83. PubMed ID: 27254756
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of perioperative factors predicting hypocalcemia after thyroid and parathyroid surgery.
Chia SH; Weisman RA; Tieu D; Kelly C; Dillmann WH; Orloff LA
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):41-5. PubMed ID: 16415428
[TBL] [Abstract][Full Text] [Related]
10. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F;
J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949
[TBL] [Abstract][Full Text] [Related]
11. The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism.
Breslau NA; McGuire JL; Zerwekh JE; Pak CY
J Clin Endocrinol Metab; 1982 Aug; 55(2):369-73. PubMed ID: 6896338
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.
Collins MT; Lindsay JR; Jain A; Kelly MH; Cutler CM; Weinstein LS; Liu J; Fedarko NS; Winer KK
J Bone Miner Res; 2005 Nov; 20(11):1944-50. PubMed ID: 16234967
[TBL] [Abstract][Full Text] [Related]
13. Auditing the Efficacy and Safety of Alfacalcidol and Calcium Therapy in Idiopathic Hypoparathyroidism.
Saha S; Goswami R
J Clin Endocrinol Metab; 2019 Apr; 104(4):1325-1335. PubMed ID: 30608544
[TBL] [Abstract][Full Text] [Related]
14. Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.
Winer KK; Yanovski JA; Cutler GB
JAMA; 1996 Aug; 276(8):631-6. PubMed ID: 8773636
[TBL] [Abstract][Full Text] [Related]
15. Recovery from Permanent Hypoparathyroidism After Total Thyroidectomy.
Kim SM; Kim HK; Kim KJ; Chang HJ; Kim BW; Lee YS; Chang HS; Park CS
Thyroid; 2015 Jul; 25(7):830-3. PubMed ID: 25905773
[TBL] [Abstract][Full Text] [Related]
16. Determinants of hypercalciuria and renal calcifications in chronic hypoparathyroidism: A cross-sectional study.
Ridder LO; Harsløf T; Sikjaer T; Underbjerg L; Rejnmark L
Clin Endocrinol (Oxf); 2021 Aug; 95(2):286-294. PubMed ID: 33756016
[TBL] [Abstract][Full Text] [Related]
17. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study.
Clarke BL; Vokes TJ; Bilezikian JP; Shoback DM; Lagast H; Mannstadt M
Endocrine; 2017 Jan; 55(1):273-282. PubMed ID: 27734257
[TBL] [Abstract][Full Text] [Related]
18. Impaired Immune Function in Patients With Chronic Postsurgical Hypoparathyroidism: Results of the EMPATHY Study.
Puliani G; Hasenmajer V; Sciarra F; Barbagallo F; Sbardella E; Pofi R; Gianfrilli D; Romagnoli E; Venneri MA; Isidori AM
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2215-e2227. PubMed ID: 33484559
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D metabolism in chronic childhood hypoparathyroidism: evidence for a direct regulatory effect of calcium.
Carpenter TO; Insogna KL; Boulware SD; Mitnick MA
J Pediatr; 1990 Feb; 116(2):252-7. PubMed ID: 2299496
[TBL] [Abstract][Full Text] [Related]
20. Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria.
Van Den Berg CJ; Kumar R; Wilson DM; Heath H; Smith LH
J Clin Endocrinol Metab; 1980 Nov; 51(5):998-1001. PubMed ID: 6893460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
